Longevity

Lifespan extension therapy:  4-Hydroxyderricin (4-HD), isolated from Ashitaba (Angelica Keiskei), increases life span via up-regulation of its target gene BubR1, 1/November/2017, 11.41 pm
Lifespan extension therapy:  4-Hydroxyderricin (4-HD), isolated from Ashitaba (Angelica Keiskei), increases life span via up-regulation of its target gene BubR1, 1/November/2017, 11.41 pm 960 720 Dr Boomi's Genom-2-Discovery Center

 What they say: Introduction:  A recent study from the Department of Genetics, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging Harvard Medical School, Boston,USA; and Department of Pharmacology, School…

read more

Molecular therapy for TIIDM and Metabolic defects: Ezetimibe (Trade name: Zetia or Ezetrol), a cholesterol lowering medication, increases Sirtuin-4 expression, augments insulin secretion, reduces metabolic stress, improves glucose uptake, promotes glucose homeostasis and prevents progression to TIIDM via down regulation of its target gene, 31/October/2017, 11.11 am
Molecular therapy for TIIDM and Metabolic defects: Ezetimibe (Trade name: Zetia or Ezetrol), a cholesterol lowering medication, increases Sirtuin-4 expression, augments insulin secretion, reduces metabolic stress, improves glucose uptake, promotes glucose homeostasis and prevents progression to TIIDM via down regulation of its target gene, 31/October/2017, 11.11 am 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from the “Duke Molecular Physiology Institute and Sarah W. Stedman Nutrition and Metabolism Center, Duke University Medical Center, Durham, NC 27701, USA; Department of…

read more

Natural product-based therapy for ageing-associated diseases: A therapeutic mix encompassing Lucidone, Asprin, and Sulforaphane (LAS) isolated from Lindera erythrocarpa Makino, Meadowsweet, and Broccoli, respectively, increases NMN/NAD levels, decreases interaction of DBC1 with PARP1, increases PARP1 activity, promotes DNA repair, augments tolerance against radiation, cancer and aging via down regulation of its target gene, 28/October/2017, 12.10 am
Natural product-based therapy for ageing-associated diseases: A therapeutic mix encompassing Lucidone, Asprin, and Sulforaphane (LAS) isolated from Lindera erythrocarpa Makino, Meadowsweet, and Broccoli, respectively, increases NMN/NAD levels, decreases interaction of DBC1 with PARP1, increases PARP1 activity, promotes DNA repair, augments tolerance against radiation, cancer and aging via down regulation of its target gene, 28/October/2017, 12.10 am 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from Department of Genetics, Paul F. Glenn Center for the Biology of Aging, Harvard Medical School, Boston, MA, USA; and Department of Pharmacology, School…

read more

Lifespan extension therapy: Ciglitazone, an anti-diabetic medication,  may increase life span via up-regulation of its target gene BubR1, 25/October/2017, 11.20 pm
Lifespan extension therapy: Ciglitazone, an anti-diabetic medication,  may increase life span via up-regulation of its target gene BubR1, 25/October/2017, 11.20 pm 960 720 Dr Boomi's Genom-2-Discovery Center

 What they say: Introduction:  A recent study from the Department of Genetics, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging Harvard Medical School, Boston,USA; and Department of Pharmacology, School…

read more

Lifespan extension therapy: Tetrahydrocannabinolic acid [THCA], found abundantly in Hemp Cannabis Sativa, among others,  may increase life span via up-regulation of its target gene BubR1, 25/October/2017, 12.38 am
Lifespan extension therapy: Tetrahydrocannabinolic acid [THCA], found abundantly in Hemp Cannabis Sativa, among others,  may increase life span via up-regulation of its target gene BubR1, 25/October/2017, 12.38 am 960 720 Dr Boomi's Genom-2-Discovery Center

 What they say: Introduction:  A recent study from the Department of Genetics, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging Harvard Medical School, Boston,USA; and Department of Pharmacology, School…

read more

Natural product-based combinatorial therapy for ageing-associated diseases and Lifespan extension: A therapeutic mix encompassing Linalool, Gastrodin, Puerarin (LGP) increases NMN/NAD levels, decreases interaction of DBC1 with PARP1, increases PARP1 activity, promotes DNA repair, augments tolerance against radiation, cancer and aging via down regulation of its target gene, 23/October/2017, 11.58 pm
Natural product-based combinatorial therapy for ageing-associated diseases and Lifespan extension: A therapeutic mix encompassing Linalool, Gastrodin, Puerarin (LGP) increases NMN/NAD levels, decreases interaction of DBC1 with PARP1, increases PARP1 activity, promotes DNA repair, augments tolerance against radiation, cancer and aging via down regulation of its target gene, 23/October/2017, 11.58 pm 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from Department of Genetics, Paul F. Glenn Center for the Biology of Aging, Harvard Medical School, Boston, MA, USA; and Department of Pharmacology, School…

read more
Start Typing